Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Oxford BioMedica ( (GB:OXB) ) just unveiled an announcement.
Oxford Biomedica PLC announced that its issued share capital as of August 31, 2025, consists of 120,182,204 ordinary shares, with no shares held in treasury. This figure represents the total number of voting rights in the company and is relevant for shareholders determining their interest in OXB under the FCA’s rules. This announcement reflects OXB’s transparency in its operations and could impact shareholder decisions regarding their stakes in the company.
The most recent analyst rating on (GB:OXB) stock is a Buy with a £930.00 price target. To see the full list of analyst forecasts on Oxford BioMedica stock, see the GB:OXB Stock Forecast page.
Spark’s Take on GB:OXB Stock
According to Spark, TipRanks’ AI Analyst, GB:OXB is a Neutral.
Oxford BioMedica’s overall score reflects strong earnings call insights and positive corporate events, indicating strategic growth and leadership confidence. However, financial performance challenges and valuation concerns moderate the score.
To see Spark’s full report on GB:OXB stock, click here.
More about Oxford BioMedica
OXB is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. With 30 years of experience, the company is a pioneer in viral vectors, collaborating with leading pharmaceutical and biotechnology firms to provide expertise in lentivirus, adeno-associated virus, adenovirus, and other viral vector types. OXB’s capabilities range from early-stage development to commercialization, supported by robust quality-assurance systems and regulatory expertise. The company offers unique technologies for viral vector manufacturing and operates facilities in the UK, France, and the US.
YTD Price Performance: 34.76%
Average Trading Volume: 175,720
Technical Sentiment Signal: Buy
Current Market Cap: £680.2M
See more data about OXB stock on TipRanks’ Stock Analysis page.